As the Chief Operating Officer at the Clinical Research Institute of Michigan, LLC, Joe Palmer brings over 20 years of extensive experience in clinical research, having been involved in more than 300 clinical trials across various phases and therapeutic areas. His expertise spans a wide...
As the Chief Operating Officer at the Clinical Research Institute of Michigan, LLC, Joe Palmer brings over 20 years of extensive experience in clinical research, having been involved in more than 300 clinical trials across various phases and therapeutic areas. His expertise spans a wide range of responsibilities, including the management of Central Institutional Review Board (IRB) submissions, where he meticulously oversees the preparation and submission of protocols, informed consent documents, investigator brochures, and IND safety reports. Joe's commitment to quality assurance is evident in his rigorous auditing processes, ensuring that all data is accurately interpreted and documented, which is crucial for maintaining compliance with Good Clinical Practice (GCP) and FDA regulations.
In his role, Joe plays a pivotal part in fostering a culture of continuous education and training among staff, providing in-service sessions that enhance their understanding of clinical trial management and regulatory requirements. His leadership has been instrumental in successfully navigating audits by sponsoring companies and government agencies, including a notable FDA audit, which underscores his dedication to maintaining the highest standards of operational excellence.
Joe's proficiency in Clinical Trial Management Systems (CTMS) and his deep understanding of oncology research further solidify his position as a key player in advancing the institute's mission. By leveraging his extensive background in protocol management and quality assurance, Joe ensures that the Clinical Research Institute of Michigan not only meets but exceeds industry benchmarks, ultimately contributing to the advancement of healthcare through innovative research solutions.